TriSalus Life (TLSI) | Stock Overview & Key Data
TriSalus Life Performance Comparison
Stock Range
Today's Range
Low: $4.49
High: $4.66
on October 6, 2025
52 Week Range
Low: $3.42
High: $5.88
on August 12, 2025
on April 29, 2025
All-Time High: $12.83 on August 7, 2023
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$232.9M
EPS
-1.15
P/E Ratio (TTM)
0.09
Forward P/E
-3.92
P/B Ratio
-7.83
PEG Ratio
0.00
Div. Yield
N/A
ROE
128.34%
Beta
0.469
Debt to Equity
-1.73
Financial Highlights
Profitability
Gross Margin
83.93%
Operating Margin
-65.39%
Profit Margin
-86.61%
Returns and Earnings
Return on Assets (TTM)
-52.51%
Return on Equity (TTM)
128.34%
EBITDA
$-30.3M
Net Income (TTM)
$-34.2M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$1.15
Quarterly Revenue Growth (YoY)
52.30%
Quarterly Earnings Growth (YoY)
52.27%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| TriSalus Life TLSI | 232.86M Micro-cap | -1.70% | -7.23% | -8.88% | -11.49% | -7.23% | 1.54% | -53.57% | -55.23% |
| Abbott Laboratories ABT | 234.39B Mega-cap | 0.78% | 1.82% | 0.11% | 2.25% | 18.64% | 19.49% | 32.22% | 22.75% |
| Boston Scientific BSX | 144.20B Large-cap | -0.88% | -9.50% | -6.71% | -1.20% | 8.88% | 15.12% | 144.77% | 136.56% |
| Monogram MGRM | 248.68M Micro-cap | 3.38% | 1.66% | 110.69% | 125.46% | 156.72% | 163.36% | -54.74% | -54.74% |
| Inogen INGN | 235.33M Micro-cap | 5.23% | 9.77% | 15.49% | 22.70% | -5.88% | -5.15% | -60.68% | -72.14% |
| CVRx CVRX | 227.78M Micro-cap | 15.36% | 11.38% | 32.37% | -29.01% | -35.86% | -0.80% | -11.66% | -65.79% |
Ownership & Short Interest
Insider Ownership
39.67%
Institutional Ownership
17.26%
Shares Short
515K
Short Ratio
4.90
Short % of Shares Outstanding
1.41%
Average 10-Day Volume
76K
Average 90-Day Volume
120K
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is TLSI's 52-week high and low?
- In the last 52 weeks, TriSalus Life reached a high of $5.88 (on April 29, 2025) and a low of $3.42 (on August 12, 2025).
- What is the market cap and P/E ratio for TLSI?
- Curious about TriSalus Life's size and valuation? Its market capitalization stands at 232.86M. When it comes to valuation, the P/E ratio (trailing twelve months) is 0.09, and the forward P/E (looking ahead) is -3.92.
- Does TLSI pay dividends? If so, what's the yield?
- As for dividends, TriSalus Life isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are TriSalus Life's main competitors or similar companies to consider before investing?
When looking at TriSalus Life, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Abbott Laboratories
ABT234.39B Healthcare Medical Devices 19.49% 32.22% Boston Scientific
BSX144.20B Healthcare Medical Devices 15.12% 144.77% Monogram
MGRM248.68M Healthcare Medical Devices 163.36% -54.74% Inogen
INGN235.33M Healthcare Medical Devices -5.15% -60.68% CVRx
CVRX227.78M Healthcare Medical Devices -0.80% -11.66% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for TriSalus Life Sciences Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of TriSalus Life's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 128.34%, the Debt to Equity ratio from the most recent quarter is -1.73, and its Gross Profit Margin stands at 83.93%.
- What is the recent revenue and earnings growth for TLSI?
- Looking at TriSalus Life's growth, its revenue over the trailing twelve months (TTM) was $36M. Compared to the same quarter last year (YoY), quarterly revenue grew by 52.30%, and quarterly earnings saw a YoY growth of 52.27%.
- How much of TLSI stock is held by insiders and institutions?
- Wondering who owns TriSalus Life stock? Company insiders (like executives and directors) hold about 39.67% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 17.26%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.